Pseudouveitis: A clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients

Medicine

Volumn 83, Issue 4, 2004, Pages 223-232

  Park, Sophie ^a   Abad, Sébastien ^a   Tulliez, Micheline ^a   Monnet, Dominique ^a   Merlat, Annabelle ^a   Gyan, Emmanuel ^a   Bouscary, Didier ^a   Dreyfus, François ^a   Grimaldi, David ^a   Dhote, Robin ^a   Rollot, Florence ^a   Kelaïdi, Charikleia ^a   Nazal, Eve Marie ^a   Brézin, Antoine P ^a   Blanche, Philippe ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; STEROID; TENIPOSIDE; VINCRISTINE;

ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; B CELL LYMPHOMA; BRAIN RADIATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; INFLAMMATION; LARGE B CELL LYMPHOMA; LUMBAR PUNCTURE; MALE; MENINGEAL METASTASIS; METASTASIS; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOCARDIAC LYMPHOMA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PSEUDOUVEITIS; RADIATION DOSE; RARE DISEASE; RETINA; RETROSPECTIVE STUDY; STEREOTAXIC SURGERY; UVEITIS; VITRECTOMY; VITREOUS OPACITY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOCOMPETENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UVEITIS; VITRECTOMY;

EID: 3242716717     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000134850.35118.46     Document Type: Article

References (41)

1. Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, Foster CS. Intraocular-central nervous system lymphoma: Clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805-1810, 10.
2. Buggage RR, Velez G, Myers-Powell B, Shen D, Whitcup SM, Chan CC. Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. Arch Ophthalmol. 1999;117:1239-1242.
3. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671-673.
4. Char DH, Ljung BM, Deschenes J, Miller TR. Intraocular lymphoma: Immunological and cytological analysis. Br J Ophthalmol. 1988;72:905-911.
5. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology. 1988;95:625-630.
6. De Angelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology. 1990;40:80-86.
7. de Boer JH, Verhagen C, Bruinenberg M, Rothova A, de Jong PT, Baarsma GS, Van der Lelij A, Ooyman FM, Bollemeijer JG, Derhaag PJ, Kijlstra A. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996;121:650-658.
8. Delwail V, Bataille B. [Chemotherapy of primary cerebral lymphoma]. Neurochirurgie. 1997;43:380-384.
9. de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999;83:448-451.
10. de Smet MD, Yamamoto JH, Mochizuki M, Gery I, Singh VK, Shinohara T, Wiggert B, Chader GJ, Nussenblatt RB. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990;110:135-142.
11. Duker JS, Shields JA, Ross M. Intraocular large cell lymphoma presenting as massive thickening of the uveal tract. Retina. 1987;7:41-45.
12. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol. 1997;115:1152-1156.
13. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987;94:1631-1639.
14. Gass JD, Sever RJ, Grizzard WS, Clarkson JG, Blumenkranz M, Wind CA, Shugarman R. Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina. 1984;4:135-143.
15. Helbig H, Cemy T, De Smet MD. [Intravitreal chemotherapy for intraocular lymphoma]. Ophthalmologe. 2003;100:145-149.
16. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988;68:835-853.
17. Johnson BL. Intraocular and central nervous system lymphoma in a cardiac transplant recipient. Ophthalmology. 1992;99:987-992.
18. Khan RB, Shi W, Thaler HT, DeAngelis LM, Abrey LE. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol. 2002;58:175-178.
19. Kirmani MH, Thomas EL, Rao NA, Laborde RP. Intraocular reticulum cell sarcoma: Diagnosis by choroidal biopsy. Br J Ophthalmol. 1987;71:748-752.
20. Ljung BM, Char D, Miller TR, Deschenes J. Intraocular lymphoma. Cytological diagnosis and the role of immunologic markers. Acta Cytol. 1988;32:840-847.
21. Marsh WL Jr, Stevenson DR, Long HJ III. Primary leptomeningeal presentation of T-cell lymphoma. Report of a patient and review of the literature. Cancer. 1983;51:1125-1131.
22. Martin DF, Chan CC, de Smet MD, Palestine AG, Davis JL, Whitcup SM, Burnier MN Jr, Nussenblatt RB. The role of chorioretinal biopsy in the management of posterior uveitis. Ophthalmology. 1993;100:705-714.
23. Messerli J, Kraft R, Komer F. [Vitrectomy in oculocerebral non-Hodgkin's lymphoma]. Ophthalmologe. 1993;90:448-451.
24. Nango K, Nishimura T, Kusaka K, Okamura A, Uyama M. [Diagnostic vitrectomy for chronic uveitis]. Nippan Ganka Gakkai Zasshi. 1993;97:1211-1219.
25. Ng S, Rosenthal MA, Ashley D, Cher L. High-dose methotrexate for primary CNS lymphoma in the elderly. Neuro-oncol. 2000;2:40-44.
26. Palexas GN, Green WR, Goldberg MF, Ding Y. Diagnostic pars plana vitrectomy report of a 21-year retrospective study. Trans Am Ophthalmol Soc. 1995;93:281-308, discussion 308-14.
27. Peyman GA. A pneumovitrector for the diagnostic biopsy of the vitreous. Ophthalmic Surg Lasers. 1996;27:246-247.
28. Plowman PN, Taylor A, Jackson AS, Lightman S, Pavesio C. Optimal therapy of primary ocular lymphoma. Clin Oncol (R Coll Radiol). 2002;14:521.
29. Ridley ME, McDonald HR, Sternberg P Jr, Blumenkranz MS, Zarbin MA, Schachat AP. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology. 1992;99:1153-1160, discussion 1160-1161.
30. Schabet M, Herrlinger U, Weller M, Barnberg M, Clemens R, Dichgans J. [New developments in diagnosis and therapy of primary non-Hodgkin's lymphoma of the central nervous system]. Nervenarzt. 1997;68:298-308.
31. Shen DF, Zhuang Z, LeHoang P, Boni R, Zheng S, Nussenblatt RB, Chan CC. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;105:1664-1669.
32. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, Pe'er J. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109:1709-1716.
33. Soussain C, Merle-Beral H, Reux I, Sutton L, Fardeau C, Gerber S, Ben Othman T, Binet JL, Lehoang P, Leblond V. A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases. Leuk Lymphoma. 1996;23:339-345.
34. Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol. 2001;19:742-749.
35. Stark N, Panek V. [Radiotherapy of lymphomas in the ocular region]. Klin Monatsbl Augenheilkd. 1970;157:693-697.
36. Strauchen JA, Dalton J, Friedman AH. Chemotherapy in the management of intraocular lymphoma. Cancer. 1989;63:1918-1921.
37. Tritten JJ, Haefliger JM, Delouche D, Bovey E, Chan CC, Guex-Crosier Y, Herbort CP. [Interleukin 10 and chronic vitritis in a case of ocular lymphoma]. Klin Monatsbl Augenheilkd. 1998;212:416-417.
38. Velez G, Yuan P, Sung C, Tansey G, Reed GF, Chan CC, Nussenblatt RB, Robinson MR. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol. 2001;119:1518-1524.
39. Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr, Chan CC, Nussenblatt RB. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100:1399-1406.
40. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol. 1997;115:1157-1160.
41. Wu HG, Kim IH, Ha SW, Park CI, Bang YJ, Huh DS. Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas. J Korean Med Sci. 1999;14:565-570.